Skip to content

What is a verapamil injection?

3 min read

Verapamil is a calcium channel blocking agent that affects the movement of calcium into heart and blood vessel cells. A verapamil injection is the intravenous (IV) formulation used primarily in emergency medical settings to quickly control dangerously fast heart rhythms. This rapid-acting treatment is distinct from its oral counterpart, which is used for long-term management of heart conditions.

Quick Summary

Verapamil injection is an intravenous calcium channel blocker used in emergency care to slow a rapid or irregular heart rate. It works by affecting the electrical impulses and calcium movement within the heart's cells, treating conditions like supraventricular tachycardia and controlling ventricular rate in atrial fibrillation.

Key Points

  • Emergency Treatment: Verapamil injection is a fast-acting, intravenous calcium channel blocker used for specific cardiac emergencies involving rapid heart rhythms.

  • Cardiac Conduction Control: It works by inhibiting calcium influx into heart muscle cells, primarily affecting the AV node to slow electrical conduction and heart rate.

  • Key Indications: The main uses include converting paroxysmal supraventricular tachycardia (PSVT) and controlling ventricular rate in atrial fibrillation/flutter.

  • Critical Contraindications: It is unsafe for patients with severe hypotension, certain heart blocks (without a pacemaker), or those receiving IV beta-blockers.

  • Requires Close Monitoring: Because of its potent effects, a verapamil injection is administered under continuous ECG and blood pressure monitoring in a hospital setting.

  • Distinction from Oral Form: The injectable form is for acute, emergency use, while oral verapamil is for long-term management of conditions like hypertension.

In This Article

What is a verapamil injection?

A verapamil injection, formally known as verapamil hydrochloride injection, is the form of the medication verapamil that is administered intravenously, directly into a vein. It is a potent antiarrhythmic drug belonging to the non-dihydropyridine class of calcium channel blockers. Given its rapid onset of action when delivered intravenously, it is a crucial tool in acute cardiac care for treating certain types of fast heart rhythms, or tachycardias. This injectable form is distinct from the oral tablets and capsules used for chronic management of conditions like hypertension or angina. The administration of a verapamil injection requires careful medical supervision, with continuous electrocardiographic (ECG) and blood pressure monitoring.

Mechanism of Action: How it Works in the Heart

The antiarrhythmic effect of verapamil is centered on its ability to inhibit the influx of calcium ions into the slow L-type calcium channels of the heart muscle and vascular smooth muscle. Specifically within the heart, this inhibition primarily impacts the sinoatrial (SA) and atrioventricular (AV) nodes, which regulate the heart's electrical conduction.

  • Slows AV Conduction: By blocking calcium influx, verapamil significantly slows conduction through the AV node. This action helps to terminate re-entrant tachycardias, which are often the cause of conditions like paroxysmal supraventricular tachycardia (PSVT).
  • Reduces Ventricular Rate: In cases of atrial fibrillation or atrial flutter with a rapid ventricular response, slowing the AV conduction helps reduce the number of impulses reaching the ventricles, thereby controlling the heart rate.
  • Decreases Myocardial Workload: Verapamil also promotes the relaxation and dilation of coronary and peripheral blood vessels. This vasodilation reduces systemic vascular resistance, decreasing the heart's workload and oxygen demand.

Medical Uses and Indications

The primary use of a verapamil injection is the rapid conversion of certain supraventricular tachycardias (SVT) to normal sinus rhythm. Its specific indications include:

  • Paroxysmal Supraventricular Tachycardia (PSVT): For patients with PSVT, verapamil is often a first-line treatment to interrupt the re-entry circuit causing the rapid heart rate and restore a normal rhythm.
  • Atrial Fibrillation and Atrial Flutter: While not a cure for these conditions, IV verapamil is used for the temporary control of a rapid ventricular rate in patients with atrial fibrillation or atrial flutter.
  • Angina: It can be used to treat unstable angina, which is chest pain caused by reduced blood flow to the heart.

It is critical to note that verapamil injections should never be used in patients with wide-complex ventricular tachycardia, as this can lead to severe hemodynamic deterioration.

Contraindications and Adverse Effects

Before administering a verapamil injection, healthcare providers must screen for conditions that would make the treatment unsafe. Contraindications include:

  • Severe hypotension (low blood pressure) or cardiogenic shock
  • Second- or third-degree atrioventricular (AV) block (unless a functioning pacemaker is present)
  • Sick sinus syndrome (unless a functioning pacemaker is present)
  • Severe congestive heart failure
  • Hypersensitivity to verapamil
  • Patients receiving intravenous beta-adrenergic blockers (e.g., propranolol) concurrently

Common side effects associated with IV verapamil include low blood pressure, slow heart rate (bradycardia), fatigue, headache, and flushing. In more severe cases, patients may experience heart failure, liver injury, or allergic reactions.

Intravenous vs. Oral Verapamil

Feature Verapamil Injection (IV) Oral Verapamil (Tablet/Capsule)
Onset of Action Very fast (within minutes) Slow (requires time for absorption)
Primary Use Acute, emergency care for arrhythmias Chronic management of heart conditions
Treatment Setting Hospital or controlled clinical environment Home or outpatient setting
Pharmacokinetics Biphasic elimination with a rapid distribution phase Undergoes extensive first-pass metabolism in the liver
Administration Slow intravenous bolus, requires monitoring Swallowed whole (some can be sprinkled)

Conclusion

A verapamil injection is a highly effective, fast-acting medication used in controlled, acute care settings to treat specific life-threatening arrhythmias. As a non-dihydropyridine calcium channel blocker, it functions by slowing electrical conduction in the heart, particularly through the AV node, to restore or control heart rate. Its use is reserved for emergency situations and is accompanied by careful monitoring due to potential adverse effects like hypotension and bradycardia. While its injectable form provides immediate relief in cardiac emergencies, its oral form serves a different purpose in the long-term management of chronic heart conditions. Healthcare providers must be aware of its specific indications and contraindications to ensure patient safety and maximize therapeutic benefit. For additional details on the approved uses and prescribing information, consult reliable sources like the FDA's DailyMed database.

Frequently Asked Questions

Verapamil injection is used to treat specific types of fast or irregular heartbeats, including paroxysmal supraventricular tachycardia (PSVT), and to control the ventricular rate in atrial fibrillation or atrial flutter.

Verapamil injection has a very rapid onset of action, typically working within minutes of administration to restore normal heart rhythm or slow the heart rate.

Common side effects include a drop in blood pressure (hypotension), a slow heart rate (bradycardia), fatigue, headache, dizziness, and flushing.

No, verapamil injection is contraindicated in several conditions, including severe low blood pressure, certain types of heart block, severe heart failure, and for patients with wide-complex ventricular tachycardia.

The injection is used for acute, emergency treatment of arrhythmias due to its rapid effect, while oral verapamil is for the chronic, long-term management of conditions like hypertension and stable angina.

A verapamil injection is administered as a slow intravenous bolus, typically over at least two minutes, by a trained healthcare professional in a controlled medical setting.

No, verapamil is not a beta-blocker. It is a calcium channel blocker, which works through a different mechanism to affect the heart. It should also not be given to patients who are receiving intravenous beta-blockers.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.